Treatment approaches developed for Western (Fitzpatrick IIII) skin do not translate safely or effectively to Indian skin and can cause paradoxical worsening or trigger new post-inflammatory hyperpigmentation (PIH) if incorrectly applied
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) were originally developed to treat type 2 diabetes, but are becoming increasingly popular for the treatment of obesity because they are effective at helping people lose weight
and the application of nuclear transfer to human embryos for fertilisation [40]
Compared to MK-677 (Ibutamoren, non-peptide oral secretagogue), Ipamorelin presents a more physiological pulsatile kinetics (peak-return-peak) versus MK-677 which produces a sustained non-pulsatile elevation that may desensitize the receptor long-term
Clinical trials show nausea rates between 20-30% in the first month, with most cases mild-to-moderate and declining by week 4-6 as your body adapts
To view a copy of this licence, visit About this article Cite this article Gan, Y., Li, G., Wei, Z